CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NANOFOL aims to create innovative folate-based nanobiodevices for diagnosing and treating chronic inflammatory diseases like atherosclerosis and rheumatoid arthritis. These devices target specific immune cells to minimize side effects and improve treatment efficiency compared to existing therapies.
NANOFOL proposes to develop a new diagnostic/therapy approach using folate based nanobiodevices (FBN) able to provide a new type of cost efficient treatment for chronic inflammatory diseases such as Atherosclerosis and Rheumatoid Arthritis with low side effects that will constitute a more advantageous solution than current therapies.
NANOFOL will achieve all that by fulfilling the following objectives: •Design , development and production of nanobiodevices (FBN) targeting directly effector cell…
UNIVERSIDADE DO MINHO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Alcobendas
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Austria, Graz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
NETHERLANDS ORGANISATION FORAPPLIED SCIENTIFIC RESEARCH
Netherlands, Den Haag
Type: Research institute
Activity type: Research Organisations
SME: No
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
Portugal, Porto
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
